United Therapeutics Research and Development Expenses 2010-2024 | UTHR
United Therapeutics research and development expenses for the twelve months ending September 30, 2024 were $0.499B, a 42.25% increase year-over-year.
- United Therapeutics annual research and development expenses for 2023 were $0.408B, a 26.35% increase from 2022.
- United Therapeutics annual research and development expenses for 2022 were $0.323B, a 40.21% decline from 2021.
- United Therapeutics annual research and development expenses for 2021 were $0.54B, a 50.99% increase from 2020.